Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday.
A number of other equities research analysts also recently commented on the stock. BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th. B. Riley initiated coverage on Tactile Systems Technology in a report on Thursday, September 26th. They issued a “buy” rating and a $23.00 target price on the stock. Finally, Oppenheimer cut Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 5th.
Check Out Our Latest Report on Tactile Systems Technology
Tactile Systems Technology Stock Performance
Institutional Investors Weigh In On Tactile Systems Technology
Institutional investors and hedge funds have recently bought and sold shares of the stock. Arcadia Investment Management Corp MI acquired a new stake in shares of Tactile Systems Technology during the third quarter worth about $29,000. Gladius Capital Management LP purchased a new position in Tactile Systems Technology during the 3rd quarter worth approximately $44,000. Quarry LP purchased a new stake in Tactile Systems Technology in the second quarter valued at approximately $46,000. Magnetar Financial LLC purchased a new stake in Tactile Systems Technology in the second quarter valued at approximately $130,000. Finally, SG Americas Securities LLC acquired a new stake in shares of Tactile Systems Technology in the third quarter valued at approximately $156,000. 83.43% of the stock is owned by hedge funds and other institutional investors.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Articles
- Five stocks we like better than Tactile Systems Technology
- What Do S&P 500 Stocks Tell Investors About the Market?
- Micron Stock Under $100: Seize the AI-Driven Upside
- How to Choose Top Rated Stocks
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- How to trade using analyst ratings
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.